1. Nishida Y., Yamashita E., and Miki, W. (2007). ‘Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using chemiluminescence detection system’, Carotenoid science, 11, pp. 16-20.
2. Brown D. R., Gough L.A., Deb S.K., et al. (2018). ‘Astaxanthin in exercise metabolism, performance and recovery: a review’, Frontiers in nutrition, 4 (76), pp. 1-9.
3. Tominaga K., Hongo N., Karato M., et al. (2012). ‘Cosmetic benefits of astaxanthin on humans subjects’, Acta biochimica polonic, 59 (1), pp. 43-47.
4. Haijian W., Huanjiang N., Anwen S., et al. (2015). ‘Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases’, Marine drugs, 13 (9), pp. 5750-5766.
5. Fassett R.G. & Coombes J.S. (2011). ‘’Astaxanthin: A Potential Therapeutic Agent inCardiovascular Disease’, Marine drugs, 9 pp. 447-465.
6. Yoshida H., Yanai H., Ito K., et al. (2010). ‘Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia’, Atherosclerosis, 209 (2), pp. 520-523.
7. Otsuka T., Shimazawa M., Inoue Y., et al. (2016). ‘Astaxanthin Protects Against Retinal Damage: Evidence from In Vivo and In Vitro Retinal Ischemia and Reperfusion Models’, Current eye research, 41 (11), pp. 1465-1472.
8. Tomohiro O., Masamitsu S., Tomohiro N., et al. (2013). ‘The Protective Effects of a Dietary Carotenoid, Astaxanthin, Against Light-Induced Retinal Damage’, Journal of pharmacological sciences’, 123, pp. 209-218.
9. Kajita M., Tsukahara H. & Kato M. (2009). ‘The Effects of a Dietary Supplement Containing Astaxanthin on the accommodation Function of the Eye in Middle-aged and Older People’, Translated from medical consultation and new remedies, 46 (3), pp. 1-7.
10. Park J.S., Chyun J.H, Kim Y.K, et al. (2010). ‘Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans’, Nutrition and metabolism, 7 (18) pp. 1-10.